Inventor · disambiguated record
Joan-En Chang-Lin
Also filed as: CHANG-LIN JOAN-EN
29 granted patents·19 pending applications·510 citations·filing 2004–2025
97Inventor score
Top patents by PatentIndex Score
48 records- 0198US8512738B2Biodegradable intravitreal tyrosine kinase implantsEDELMAN JEFFREY L·Filed 2005·Granted Aug 20, 2013·89 cites·6 claims
- 0298US7931909B2Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance ratesALLERGAN INC·Filed 2006·Granted Apr 26, 2011·64 cites·9 claims
- 0397US8933120B2Enhanced bimatoprost ophthalmic solutionALLERGAN INC·Filed 2013·Granted Jan 13, 2015·13 cites·20 claims
- 0497US8409607B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsHUGHES PATRICK M·Filed 2008·Granted Apr 2, 2013·81 cites·8 claims
- 0597US8309605B2Enhanced bimatoprost ophthalmic solutionCHANG CHIN-MING·Filed 2010·Granted Nov 13, 2012·20 cites·21 claims
- 0697US8278353B2Enhanced bimatoprost ophthalmic solutionCHANG CHIN-MING·Filed 2012·Granted Oct 2, 2012·16 cites·30 claims
- 0797US7851504B2Enhanced bimatoprost ophthalmic solutionALLERGAN INC·Filed 2005·Granted Dec 14, 2010·24 cites·3 claims
- 0896US8571802B2Method for determining optimum intraocular locations for drug delivery systemsROBINSON MICHAEL R·Filed 2007·Granted Oct 29, 2013·30 cites·5 claims
- 0996US8299118B2Enhanced bimatoprost ophthalmic solutionCHANG CHIN-MING·Filed 2012·Granted Oct 30, 2012·27 cites·30 claims
- 1095US8586630B2Enhanced bimatoprost ophthalmic solutionALLERGAN INC·Filed 2012·Granted Nov 19, 2013·8 cites·20 claims
- 1194US7771742B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsALLERGAN INC·Filed 2004·Granted Aug 10, 2010·47 cites·15 claims
- 1293US8772338B2Enhanced bimatoprost ophthalmic solutionALLERGAN INC·Filed 2013·Granted Jul 8, 2014·5 cites·20 claims
- 1393US8524777B2Enhanced bimatoprost ophthalmic solutionCHANG CHIN-MING·Filed 2012·Granted Sep 3, 2013·7 cites·28 claims
- 1492US9233070B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2013·Granted Jan 12, 2016·6 cites·5 claims
- 1591US9241918B2Enhanced bimatoprost ophthalmic solutionCHANG CHIN-MING·Filed 2010·Granted Jan 26, 2016·5 cites·8 claims
- 1691US8569370B2Ophthalmic compositions and methods for treating eyesALLERGAN INC·Filed 2013·Granted Oct 29, 2013·9 cites·16 claims
- 1791US8338479B2Enhanced bimatoprost ophthalmic solutionCHANG CHIN-MING·Filed 2009·Granted Dec 25, 2012·10 cites·16 claims
- 1890US9155716B2Enhanced bimatoprost ophthalmic solutionALLERGAN INC·Filed 2013·Granted Oct 13, 2015·4 cites·12 claims
- 1989US8729125B2Ophthalmic compositions and methods for treating eyesALLERGAN INC·Filed 2013·Granted May 20, 2014·7 cites·13 claims
- 2088US8933127B2Enhanced bimatoprost ophthalmic solutionCHANG CHIN-MING·Filed 2012·Granted Jan 13, 2015·3 cites·21 claims
- 2187US10213405B2Ophthalmic compositions and methods for treating eyesALLERGAN INC·Filed 2017·Granted Feb 26, 2019·3 cites·7 claims
- 2287US10076492B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2016·Granted Sep 18, 2018·4 cites·4 claims
- 2386US8569367B2Ophthalmic compositions and methods for treating eyesVEHIGE JOSEPH G·Filed 2004·Granted Oct 29, 2013·16 cites·18 claims
- 2486US2023404961A1Ophthalmic compositions and methods for treating eyesALLERGAN INC·Filed 2023·Application pending·0 cites
- 2585US10881608B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2018·Granted Jan 5, 2021·1 cites·7 claims
- 2685US7714024B2Compositions and methods for the intraocular transport of therapeutic agentsALLERGAN INC·Filed 2006·Granted May 11, 2010·6 cites·6 claims
- 2780US2025186385A1Ophthalmic compositions and methods for treating eyesALLERGAN INC·Filed 2025·Application pending·0 cites
- 2879US8404267B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsHUGHES PATRICK M·Filed 2008·Granted Mar 26, 2013·2 cites·3 claims
- 2978US2021401789A1Ophthalmic compositions and methods for treating eyesALLERGAN INC·Filed 2021·Application pending·0 cites
- 3077US9668997B2Ophthalmic compositions and methods for treating eyesALLERGAN INC·Filed 2016·Granted Jun 6, 2017·1 cites·18 claims
- 3177US2015087713A1Enhanced bimatoprost ophthalmic solutionALLERGAN INC·Filed 2014·Application pending·0 cites
- 3276US9254324B2Ophthalmic compositions and methods for treating eyesALLERGAN INC·Filed 2014·Granted Feb 9, 2016·1 cites·22 claims
- 3374US2009163550A1Retinoid-containing sustained release intraocular implants and related methodsALLERGAN INC·Filed 2009·Application pending·0 cites
- 3473US2021121397A1Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2021·Application pending·0 cites
- 3571US8637571B2Compositions and methods for the intraocular transport of therapeutic agentsHUGHES PATRICK M·Filed 2010·Granted Jan 28, 2014·1 cites·5 claims
- 3670US2016250225A1Enhanced bimatoprost ophthalmic solutionALLERGAN INC·Filed 2015·Application pending·0 cites
- 3770US2019365692A1Ophthalmic compositions and methods for treating eyesALLERGAN INC·Filed 2019·Application pending·0 cites
- 3866US2016354384A1Enhanced bimatoprost ophthalmic solutionALLERGAN INC·Filed 2016·Application pending·0 cites
- 3961US2008112923A1Ocular therapy using alpha-2 adrenergic receptor anterior compounds having enhanced clearance ratesALLERGAN INC·Filed 2007·Application pending·0 cites
- 4061US2008112922A1Ocular therapy using alpha-2 adrenergic receptor anterior compounds having enhanced clearance ratesALLERGAN INC·Filed 2007·Application pending·0 cites
- 4158US2011076318A1Retinoid-containing sustained release intraocular implants and related mattersALLERGAN INC·Filed 2010·Application pending·0 cites
- 4256US2016015717A1Enhanced bimatoprost ophthalmic solutionALLERGAN INC·Filed 2015·Application pending·0 cites
- 4354US2010056547A1OPHTHALMIC COMPOSITIONS COMPRISING dDCALLERGAN INC·Filed 2006·Application pending·0 cites
- 4454US2005271705A1Retinoid-containing sustained release intraocular drug delivery system and related methodsALLERGAN INC·Filed 2005·Application pending·0 cites
- 4553US2005234018A1Drug delivery to the back of the eyeALLERGAN INC·Filed 2004·Application pending·0 cites
- 4653US2006182781A1Methods for treating ocular conditions with cyclic lipid contraining microparticlesALLERGAN INC·Filed 2006·Application pending·0 cites
- 4752US2006258617A1Drug delivery to the back of the eyeALLERGAN INC·Filed 2006·Application pending·0 cites
- 4852US2014010823A1Method for determining optimum intraocular locations for drug delivery systemsALLERGAN INC·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →